Daiichi Sankyo Company, Ltd (TSE: 4568) has appointed Hiroyuki Okuzawa, 62, to succeed Sunao Manabe, DVM, Ph.D. as Chief ...

(This Feb 6. story has been corrected to show the damages are according to an expert report, and not estimated by IHH's unit.

Tokyo: Daiichi Sankyo Company, Ltd has appointed Hiroyuki Okuzawa, 62, to succeed Sunao Manabe, DVM, Ph.D. as Chief Executive ...

Daiichi Sankyo announced that Hiroyuki Okuzawa will serve as its ... that operate continuously and cutting-edge software for automated orchestration and data management, the laboratory is set to ...

The Japanese pharma had one asset rejected by the FDA and withdrew a regulatory application for another, but already this ...

In order to ensure the solid achievement of FY2025 goals and to strengthen its management structure, Daiichi Sankyo’s Board ... for two years and other senior leadership roles in international ...